Literature DB >> 26245673

Challenges Associated with Route of Administration in Neonatal Drug Delivery.

Matthew W Linakis1,2, Jessica K Roberts1, Anita C Lala3, Michael G Spigarelli1, Natalie J Medlicott4, David M Reith3, Robert M Ward1,5,6, Catherine M T Sherwin7.   

Abstract

The administration of drugs to neonates poses significant challenges. The aim of this review was to provide insight into some of these challenges and resolutions that may be encountered with several of the most commonly used routes of administration and dosage forms in neonatal care, including oral, parenteral, transdermal, intrapulmonary, and rectal. Important considerations include fluctuations in stomach pH hours to years after birth, the logistics of setting up an intravenous infusion, the need for reduced particle size for aerosol delivery to the developing neonatal lung, and variation in perirectal venous drainage. Additionally, some of the recently developed technologies for use in neonatal care are described. While the understanding of neonatal drug delivery has advanced over the past several decades, there is still a deficiency of technologies and formulations developed specifically for this population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26245673     DOI: 10.1007/s40262-015-0313-z

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  122 in total

1.  In vitro determination of the optimal particle size for nebulized aerosol delivery to infants.

Authors:  Karen G Schüepp; Juergen Jauernig; Hettje M Janssens; Harm A W M Tiddens; Daniel A Straub; Roland Stangl; Manfred Keller; Johannes H Wildhaber
Journal:  J Aerosol Med       Date:  2005

2.  Prevention of drug delivery disturbances during continuous intravenous infusion: an in vitro study on a new multi-lumen infusion access device.

Authors:  A Foinard; B Décaudin; C Barthélémy; B Debaene; P Odou
Journal:  Ann Fr Anesth Reanim       Date:  2013-08-16

3.  Y-site compatibility of medications with parenteral nutrition.

Authors:  Christine A Robinson; Jaclyn E Sawyer
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

4.  Peripherally inserted central venous catheters: frequency of complications in premature newborn depends on the insertion site.

Authors:  P Panagiotounakou; G Antonogeorgos; E Gounari; S Papadakis; J Labadaridis; A K Gounaris
Journal:  J Perinatol       Date:  2014-03-13       Impact factor: 2.521

5.  Gastric acidity in the first day of life.

Authors:  G B Avery; J G Randolph; T Weaver
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

6.  Nonnutritive sucking and oral sucrose relieve neonatal pain during intramuscular injection of hepatitis vaccine.

Authors:  Jen-Jiuan Liaw; Wen-Ping Zeng; Luke Yang; Yeong-Seng Yuh; Ti Yin; Meei-Horng Yang
Journal:  J Pain Symptom Manage       Date:  2011-05-26       Impact factor: 3.612

7.  Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach.

Authors:  Amélie Marsot; Véronique Brevaut-Malaty; Renaud Vialet; Audrey Boulamery; Bernard Bruguerolle; Nicolas Simon
Journal:  Fundam Clin Pharmacol       Date:  2013-07-16       Impact factor: 2.748

8.  Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.

Authors:  R A van Lingen; J T Deinum; J M Quak; A J Kuizenga; J G van Dam; K J Anand; D Tibboel; A Okken
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

9.  Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors.

Authors:  J B Fink; R Dhand; J Grychowski; P J Fahey; M J Tobin
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

10.  Polysorbate 80 and E-Ferol toxicity.

Authors:  S L Alade; R E Brown; A Paquet
Journal:  Pediatrics       Date:  1986-04       Impact factor: 7.124

View more
  4 in total

1.  Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care.

Authors:  Karel Allegaert; Catherine Sherwin
Journal:  Eur J Pediatr       Date:  2016-01-07       Impact factor: 3.183

Review 2.  Neonatal pharmacology and clinical implications.

Authors:  Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Pietro Ferrara; Giorgio Attinà
Journal:  Drugs Context       Date:  2019-10-14

Review 3.  Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

4.  Off-label use of combined antiretroviral therapy, analysis of data collected by the Italian Register for HIV-1 infection in paediatrics in a large cohort of children.

Authors:  Elena Chiappini; Catiuscia Lisi; Vania Giacomet; Paola Erba; Stefania Bernardi; Paola Zangari; Antonio Di Biagio; Lucia Taramasso; Carlo Giaquinto; Osvalda Rampon; Clara Gabiano; Silvia Garazzino; Claudia Tagliabue; Susanna Esposito; Eugenia Bruzzese; Raffaele Badolato; Domenico Zanaboni; Monica Cellini; Maurizio Dedoni; Antonio Mazza; Andrea Pession; Anna Maria Giannini; Filippo Salvini; Icilio Dodi; Ines Carloni; Salvatore Cazzato; Pier Angelo Tovo; Maurizio de Martino; Luisa Galli
Journal:  BMC Infect Dis       Date:  2022-01-15       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.